Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-12-26
pubmed:abstractText
Paclitaxel has shown promising activity in gastric cancer and has synergism with cisplatin. This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel (145 mg/m(2)) plus cisplatin chemotherapy in metastatic or relapsed gastric cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0368-2811
pubmed:author
pubmed:issnType
Print
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
720-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16332718-Adenocarcinoma, pubmed-meshheading:16332718-Adult, pubmed-meshheading:16332718-Aged, pubmed-meshheading:16332718-Anemia, pubmed-meshheading:16332718-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16332718-Cisplatin, pubmed-meshheading:16332718-Dose-Response Relationship, Drug, pubmed-meshheading:16332718-Drug Administration Schedule, pubmed-meshheading:16332718-Female, pubmed-meshheading:16332718-Humans, pubmed-meshheading:16332718-Liver Neoplasms, pubmed-meshheading:16332718-Lymphatic Metastasis, pubmed-meshheading:16332718-Male, pubmed-meshheading:16332718-Maximum Tolerated Dose, pubmed-meshheading:16332718-Middle Aged, pubmed-meshheading:16332718-Neutropenia, pubmed-meshheading:16332718-Paclitaxel, pubmed-meshheading:16332718-Peritoneal Neoplasms, pubmed-meshheading:16332718-Stomach Neoplasms, pubmed-meshheading:16332718-Vomiting, Anticipatory
pubmed:year
2005
pubmed:articleTitle
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer.
pubmed:affiliation
Department of Internal Medicine, Seoul National University College of Medicine, Chongno-Gu, Seoul 110-744, Republic of Korea.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II